Aileron Therapeutics announced today that its collaborators, James E. Bradner, M.D., of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, Ph.D., professor of chemistry at Harvard University, published res ...
Source:
DISCLAIMER
Monday, November 16, 2009